| Company Name: |
Guangzhou Isun Pharmaceutical Co., Ltd
|
| Tel: |
020-39119399 18927568969 |
| Email: |
isunpharm@qq.com |
| Products Intro: |
Product Name:Quininib
CAS:143816-42-6
Purity:98% (HPLC) Package:5MG; 25MG; 100MG; 1G
|
| Company Name: |
ATK CHEMICAL COMPANY LIMITED
|
| Tel: |
021-51619050 13301662590 |
| Email: |
mandy@atkchemical.com |
| Products Intro: |
Product Name:Phenol, 2-[(1E)-2-(2-quinolinyl)ethenyl]-
CAS:143816-42-6
Purity:98% HPLC Package:5MG;10MG;50MG;100MG,1G,5G
|
Quininib manufacturers
- Quininib
-
- $595.00 / 5mg
-
2024-10-28
- CAS:143816-42-6
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Quininib Basic information |
| Product Name: | Quininib | | Synonyms: | Quininib;(E)-2-(2-(quinolin-2-yl)vinyl)phenol;Phenol, 2-[(1E)-2-(2-quinolinyl)ethenyl]-;Quininib >=98% (HPLC);2-[(1E)-2-(2-quinolinyl)ethenyl]-phenol | | CAS: | 143816-42-6 | | MF: | C17H13NO | | MW: | 247.29 | | EINECS: | | | Product Categories: | | | Mol File: | 143816-42-6.mol |  |
| | Quininib Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO: soluble | | form | A crystalline solid |
| | Quininib Usage And Synthesis |
| Description | Quininib is an antagonist of the cysteinyl leukotriene 1 (CysLT1) and CysLT2 receptors (IC50s = 1.4 and 52 μM, respectively). It inhibits tubule formation in HMEC-1 cells when used at concentrations of 3.16 and 10 μM and inhibits sprout formation in isolated mouse aortic rings in an ex vivo model of angiogenesis when used at 10 μM. Quininib (3 μM) decreases angiogenesis in an oxygen-induced retinopathy mouse model of ocular angiogenesis, preventing revascularization when used at concentrations of 0.5 and 3 μM, as well as increasing neovascularization and vascular density when used at 3 μM. It reduces tumor growth and inhibits angiogenesis in an HT-29 colorectal cancer mouse xenograft model when administered at a dose of 50 mg/kg every three days. | | Uses | Quininib is a novel regulator of Ocular Angiogenesis, significantly inhibiting angiogenic tubule formation in HMEC-1 cells, angiogenic sprouting in aortic ring explants and retinal revascularisation in OIR mice. | | Definition | ChEBI: Quininib is a styrylquinoline that is trans-2-styrylquinoline in which the the phenyl group has been substituted at position 2 by a hydroxy group. It is an anti-angiogenic compound that exerts a dose-dependent antagonism of the cysteinyl leukotriene pathway, preferentially antagonising cysteinyl leukotriene receptor 1. The major species at pH 7.3 It has a role as an angiogenesis inhibitor. It is a styrylquinoline and a member of phenols. It is functionally related to a trans-2-styrylquinoline. It is a conjugate base of a quininib(1+). |
| | Quininib Preparation Products And Raw materials |
|